Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
21.90
-0.29 (-1.31%)
At close: Mar 30, 2026, 4:00 PM EDT
21.37
-0.53 (-2.42%)
After-hours: Mar 30, 2026, 7:37 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.17 billion as of March 30, 2026. Its market cap has decreased by -7.71% in one year.
Market Cap
2.17B
Enterprise Value
1.08B
1-Year Change
-7.71%
Ranking
Category
Stock Price
$21.90
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.17B, an increase of 563.15%. That is a compound annual growth rate of 36.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 2.17B | -20.50% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.32B |
| Veradermics | 2.27B |
| Oruka Therapeutics | 2.26B |
| Day One Biopharmaceuticals | 2.21B |
| Ascentage Pharma Group International | 2.19B |
| Enliven Therapeutics | 2.19B |
| Apellis Pharmaceuticals | 2.18B |
| Immunome | 2.18B |